EICHOR
● Active Not Recruiting
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia · Sponsor: Janssen Research & Development, LLC
About this study
The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (171)
| MemorialCare Medical Group | Fountain Valley, California, United States | — |
| University of Southern California | Los Angeles, California, United States | — |
| Compassionate Cancer Care | Riverside, California, United States | — |
| American Institute of Research | Whittier, California, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| GNP Research | Cooper City, Florida, United States | — |
| University of Florida College of Medicine | Gainesville, Florida, United States | — |
| 21st Century Oncology | Jacksonville, Florida, United States | — |
| Lakes Research | Miami Lakes, Florida, United States | — |
| AdventHealth Cancer Institute | Orlando, Florida, United States | — |
| Children's Research Institute | St. Petersburg, Florida, United States | — |
| Rush University Medical Center | Chicago, Illinois, United States | — |
+ 159 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.